[Inflammatory tuberculoid leprosy and borderline leprosy treated with long-acting sulfamides (fanasil). Clinical, bacteriologic and immunologic changes in vivo and in vitro followed for 18 to 36 months].
D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000276:immunology; D013413:Sulfadoxine / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*
D013424:Sulfanilamides; D013413:Sulfadoxine
Lèpres TT inflammatoires et BT traitées par sulfamides long retard (Fanasil). Evolution clinique, bactériologique et immunologique in vitro et in vivo suivie pendant 18 à 36 mois.